Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):17-22. doi: 10.1161/CIRCEP.113.001110. Epub 2014 Jan 14.
Left ventricular (LV) pacing through the coronary sinus is the standard approach for cardiac resynchronization therapy. When this route is unavailable, the alternatives have major limitations. LV endocardial pacing through the interventriuclar septum may offer a simpler solution. We describe an initial case series to demonstrate technical feasibility and to describe our refinement of the puncture technique.
Ten patients with previous failed coronary sinus lead implant or with nonresponse to cardiac resynchronization therapy and a suboptimal LV lead position were selected. All patients were anticoagulated. Left ventriculography and coronary angiography were performed to identify LV borders and septal vessels. Subclavian vein access was used for a superior approach ventricular transseptal puncture under fluoroscopic guidance, using a steerable sheath and a standard transseptal needle, radiofrequency needle, or radiofrequency energy delivered through a guidewire. An active-fixation pacing lead was successfully delivered to the endocardial wall of the lateral LV in all patients (9 men; age, 62±10 years). LV lead implant procedure time shortened with experience. The use of radiofrequency energy delivered through a guidewire was the most effective technique. Mean threshold and R wave at implant were 0.8±0.3 V and 10.8±3.9 mV. At follow-up (mean, 8.7 months; minimum, 0; and maximum 19), thresholds were stable, and there were no thromboembolic events. Of 9 patients, 8 were classed as clinical responders (1 had inadequate follow-up to assess response).
LV endocardial pacing through a ventricular septal puncture is a feasible approach for cardiac resynchronization therapy.
通过冠状窦进行左心室(LV)起搏是心脏再同步治疗的标准方法。当这条路径不可用时,替代方法存在重大局限性。通过室间隔进行 LV 心内膜起搏可能提供更简单的解决方案。我们描述了一个初始病例系列,以证明技术可行性,并描述我们对穿刺技术的改进。
选择了 10 例先前冠状窦导联植入失败或对心脏再同步治疗无反应且 LV 导联位置不佳的患者。所有患者均接受抗凝治疗。进行左心室造影和冠状动脉造影,以识别 LV 边界和间隔血管。经锁骨下静脉入路,在透视引导下使用可转向护套和标准经间隔穿刺针、射频针或通过导丝传递射频能量,进行心尖室间隔穿刺。所有患者(9 名男性;年龄 62±10 岁)均成功将主动固定起搏导联输送到 LV 心外膜的侧壁。随着经验的积累,LV 导联植入程序时间缩短。通过导丝传递射频能量是最有效的技术。植入时的平均阈值和 R 波为 0.8±0.3 V 和 10.8±3.9 mV。在随访(平均 8.7 个月;最短 0 个月,最长 19 个月)时,阈值稳定,无血栓栓塞事件。在 9 例患者中,8 例被归类为临床反应者(1 例因随访不足而无法评估反应)。
通过心室间隔穿刺进行 LV 心内膜起搏是心脏再同步治疗的一种可行方法。